AB-189
23 Jul 2026
15:55
16:00
Patient-Borne Medical Cost and Societal Cost of Total Neoadjuvant Therapy versus Conventional Chemoradiotherapy for Locally Advanced Rectal Cancer: A Prespecified Analysis of the TV-LARK Randomized Trial